SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form SC 13G - Statement of Beneficial Ownership by Certain Investors:
SEC Accession No. 0001144204-17-020576
Filing Date
2017-04-17
Accepted
2017-04-14 20:43:24
Documents
2
Group Members
BRIAN D. GROSSMANCHRISTOPHER M. JAMESPARTNER FUND MANAGEMENT GP, LLCPARTNER INVESTMENT MANAGEMENT GP, LLCPARTNER INVESTMENT MANAGEMENT, L.P.

Document Format Files

Seq Description Document Type Size
1 SC 13G v464242_sc13g.htm SC 13G 142270
2 EXHIBIT 99.1 v464242_ex99-1.htm EX-99.1 11716
  Complete submission text file 0001144204-17-020576.txt   155898
Mailing Address 5 SYLVAN WAY SUITE 300 PARSIPPANY NJ 07054
Business Address 5 SYLVAN WAY SUITE 300 PARSIPPANY NJ 07054 973-254-3560
Pacira Pharmaceuticals, Inc. (Subject) CIK: 0001396814 (see all company filings)

IRS No.: 510619477 | Fiscal Year End: 1231
Type: SC 13G | Act: 34 | File No.: 005-86096 | Film No.: 17763428
SIC: 2834 Pharmaceutical Preparations

Mailing Address FOUR EMBARCADERO CENTER SUITE 3500 SAN FRANCISCO CA 94111
Business Address FOUR EMBARCADERO CENTER SUITE 3500 SAN FRANCISCO CA 94111 415-281-1022
Partner Fund Management, L.P. (Filed by) CIK: 0001442756 (see all company filings)

IRS No.: 262000428 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13G